Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New research initiated by the Belgian Health Care Knowledge Center

The Belgian Health Care Knowledge Center (KCE) is a semi-governmental body that produces scientific reports that support efficient health policy decisions. 

In March 2024, KCE launched the development of two new Health Services Research reports: 

  • Accountability mechanisms in the introduction of DRG-based lump-sum financing of hospitals in Belgium; 

  • Indirect costs in hospital financing. 

No further information and timelines for the finalization of research are available. 

See more details in French here and here. 

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.